ATE443076T1 - Von protease typ ii spaltbares peptid - Google Patents
Von protease typ ii spaltbares peptidInfo
- Publication number
- ATE443076T1 ATE443076T1 AT99930951T AT99930951T ATE443076T1 AT E443076 T1 ATE443076 T1 AT E443076T1 AT 99930951 T AT99930951 T AT 99930951T AT 99930951 T AT99930951 T AT 99930951T AT E443076 T1 ATE443076 T1 AT E443076T1
- Authority
- AT
- Austria
- Prior art keywords
- tropoelastin
- amino acid
- derivatives
- claveable
- peptide
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title abstract 4
- 239000004365 Protease Substances 0.000 title abstract 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 108010014258 Elastin Proteins 0.000 abstract 4
- 102100033167 Elastin Human genes 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 239000000816 peptidomimetic Substances 0.000 abstract 3
- 101000851054 Homo sapiens Elastin Proteins 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP4723A AUPP472398A0 (en) | 1998-07-17 | 1998-07-17 | Protease susceptibility II |
| PCT/AU1999/000580 WO2000004043A1 (en) | 1998-07-17 | 1999-07-19 | Protease susceptibility ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE443076T1 true ATE443076T1 (de) | 2009-10-15 |
Family
ID=3808961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99930951T ATE443076T1 (de) | 1998-07-17 | 1999-07-19 | Von protease typ ii spaltbares peptid |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7229788B1 (de) |
| EP (1) | EP1100815B1 (de) |
| JP (1) | JP4342731B2 (de) |
| AT (1) | ATE443076T1 (de) |
| AU (1) | AUPP472398A0 (de) |
| CA (1) | CA2335098C (de) |
| DE (1) | DE69941433D1 (de) |
| WO (1) | WO2000004043A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2393724B (en) * | 2002-10-01 | 2006-04-12 | Johnson & Johnson Medical Ltd | Controlled release therapeutic wound dressings |
| PL3566713T3 (pl) | 2009-03-10 | 2021-12-06 | Allergan Pharmaceuticals International Limited | Wstrzykiwalne biomateriały |
| GB201102189D0 (en) * | 2011-02-08 | 2011-03-23 | King S College London | Materials and methods relating to cardiovascular imaging |
| TR201905884T4 (tr) | 2011-09-30 | 2019-05-21 | Allergan Pharmaceuticals Int Ltd | Elastik fiberin in vivo sentezi. |
| FR2986233B1 (fr) * | 2012-02-01 | 2014-02-28 | Regentis Internat | Peptide bifonctionnel |
| WO2014063194A1 (en) | 2012-10-23 | 2014-05-01 | The University Of Sydney | Elastic hydrogel |
| CA2933047A1 (en) | 2012-12-10 | 2014-06-19 | Allergan Pharmaceuticals International Limited | Scalable three-dimensional elastic construct manufacturing |
| CN110464837A (zh) | 2013-08-13 | 2019-11-19 | 爱力根制药国际有限公司 | 受损组织的再生 |
| AU2015209330A1 (en) * | 2014-01-27 | 2016-07-28 | Auspex Pharmaceuticals, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| US20190275087A1 (en) | 2018-03-01 | 2019-09-12 | Allergan Pharmaceuticals International Limited | Expansion and differentiation of stem cells |
| SG11202111349QA (en) | 2019-04-12 | 2021-11-29 | Geltor Inc | Recombinant elastin and production thereof |
| AU2020270005A1 (en) | 2019-05-03 | 2022-01-06 | Allergan Pharmaceuticals International Limited | Scar prevention and/or treatment |
| ES3024564T3 (en) | 2019-08-23 | 2025-06-04 | Allergan Pharmaceuticals Int Ltd | Tropoelastin for use in treatment of acne scarring |
| US20230040485A1 (en) | 2019-12-18 | 2023-02-09 | Allergan Pharmaceuticals International Limited | Hybrid polymeric materials and uses thereof |
| AU2021217239A1 (en) | 2020-02-06 | 2022-09-22 | Allergan Pharmaceuticals International Limited | Tissue engineering scaffolds |
| CA3177686A1 (en) | 2020-05-14 | 2021-11-18 | Allergan Pharmaceuticals International Limited | Compositions comprising tropoelastin crosslinked to hyaluronic acid and methods of use thereof |
| CN111704653B (zh) * | 2020-06-08 | 2023-10-03 | 深圳市图微安创科技开发有限公司 | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3474190B2 (ja) | 1992-12-22 | 2003-12-08 | ザ ユニバーシテイ オブ シドニイ | 合成ポリヌクレオチド |
| US5726040A (en) | 1993-11-10 | 1998-03-10 | Ensley; Burt D. | Cosmetic compositions including tropoelastin isomorphs |
| US7001328B1 (en) * | 1994-11-15 | 2006-02-21 | Kenton W. Gregory | Method for using tropoelastin and for producing tropoelastin biomaterials |
| US6451326B2 (en) | 1996-05-02 | 2002-09-17 | Burt D. Ensley | Cosmetic compositions |
| US5969106A (en) | 1996-08-07 | 1999-10-19 | The Hospital For Sick Children | Self-aligning peptides modeled on human elastin and other fibrous proteins |
| AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
| AU741851B2 (en) * | 1997-07-18 | 2001-12-13 | Elastagen Pty Ltd | Tropoelastin derivatives |
-
1998
- 1998-07-17 AU AUPP4723A patent/AUPP472398A0/en not_active Abandoned
-
1999
- 1999-07-19 AT AT99930951T patent/ATE443076T1/de not_active IP Right Cessation
- 1999-07-19 US US09/743,818 patent/US7229788B1/en not_active Expired - Lifetime
- 1999-07-19 DE DE69941433T patent/DE69941433D1/de not_active Expired - Lifetime
- 1999-07-19 JP JP2000560149A patent/JP4342731B2/ja not_active Expired - Lifetime
- 1999-07-19 CA CA2335098A patent/CA2335098C/en not_active Expired - Lifetime
- 1999-07-19 WO PCT/AU1999/000580 patent/WO2000004043A1/en not_active Ceased
- 1999-07-19 EP EP99930951A patent/EP1100815B1/de not_active Expired - Lifetime
-
2007
- 2007-05-08 US US11/801,120 patent/US20080058261A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7229788B1 (en) | 2007-06-12 |
| AUPP472398A0 (en) | 1998-08-13 |
| DE69941433D1 (de) | 2009-10-29 |
| JP2002520421A (ja) | 2002-07-09 |
| EP1100815A4 (de) | 2005-05-25 |
| US20080058261A1 (en) | 2008-03-06 |
| EP1100815A1 (de) | 2001-05-23 |
| CA2335098A1 (en) | 2000-01-27 |
| EP1100815B1 (de) | 2009-09-16 |
| JP4342731B2 (ja) | 2009-10-14 |
| WO2000004043A1 (en) | 2000-01-27 |
| CA2335098C (en) | 2012-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE443076T1 (de) | Von protease typ ii spaltbares peptid | |
| YU8997A (sh) | Prečišćen protein koji ima serinsku proteaznu inhibitorsku aktivnost i farmaceutski preparat koji ga sadrži | |
| MXPA03010079A (es) | Formulaciones de oxicodona de administracion una vez al dia. | |
| WO2002026947A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2001072977A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002034922A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002042437A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002046407A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002016566A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2002050286A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2002077166A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2001081412A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
| WO2002046406A3 (en) | Human transporter proteins, nucleic acid molecules encoding them,and uses thereof | |
| WO2001081413A3 (en) | Isolated human transporter proteins, nucleic acids and uses thereof | |
| WO2002050283A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002018554A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof | |
| WO2002033086A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002046217A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002024748A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002020757A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide | |
| WO2002024910A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
| WO2002057310A3 (en) | Human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
| WO2001090360A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002066642A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |